973,759
Participants
Start Date
February 28, 2018
Primary Completion Date
February 29, 2020
Study Completion Date
February 29, 2020
PROUD Intervention
The PROUD intervention includes 3 strategies used to implement the MA Model: 1. Clinic leadership receives funding for a 1.0 full time equivalent NCM for 2 years after randomization and technical support for recruiting and hiring the NCM. Once hired for the study, the NCM will receive technical assistance (TA) from experts at Boston Medical Center (BMC) supported by PROUD, but NCMs will be employed and supervised by the health system. 2. Experts at BMC who originally developed and disseminated the MA Model will: provide intervention clinics with a Manual; train PROUD NCMs at BMC; and provide the ongoing TA for 2 years after randomization. 3. At least 3 primary care providers in the PROUD intervention clinic will obtain DEA waivers to prescribe buprenorphine for OUDs, if not already waivered, and work closely with the NCM to offer high quality primary care for OUDs (e.g. medication treatment with buprenorphine or naltrexone with close follow-up to maximize retention in treatment).
Montefiore Medical Center, The Bronx
University of Miami Health System, Miami
Henry Ford Health System, Detroit
Harris Health System, Houston
Kaiser Permanente Washington, Seattle
MultiCare Health System, Tacoma
National Institute on Drug Abuse (NIDA)
NIH
The Emmes Company, LLC
INDUSTRY
Kaiser Permanente
OTHER